OXLUMO 94.5 mg / 0.5 ml sol inj 94.5 mg 1 pce

7680682390014 CH-68239 A16AX18 04.99.0.
OXLUMO 94.5 mg / 0.5 ml sol inj 94.5 mg 1 pce
OXLUMO 94.5 mg / 0.5 ml sol inj 94.5 mg 1 pce
OXLUMO 94.5 mg / 0.5 ml sol inj 94.5 mg 1 pce
1 / 3
google

Details

GTIN
7680682390014
Pharmacode
-
Product number
6823901
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
lumasiranum 94.5 mg corresp. lumasiranum natricum, aqua ad iniectabile, acidum phosphoricum, natrii hydroxidum, nitrogenium, ad solutionem pro 0.5 ml.

Articles (1)

Oxlumo 94.5 mg / 0.5 ml, Injektionslösung
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
07/02/2026
Professional SmPC
Français
07/02/2026
Professional SmPC
Italien
07/02/2026
Patient information leaflet
Allemand
04/02/2026
Patient information leaflet
Français
04/02/2026
Patient information leaflet
Italien
04/02/2026

Detailed composition

Substance Quantity Type Category
lumasiranum
94.5 MG Substance Wirkstoff (Principe actif)
lumasiranum natricum
- Substance WIZUS
aqua ad iniectabile
- Substance HNIDK
acidum phosphoricum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
nitrogenium
- Substance TRGAS

Authorization holder

Alnylam Switzerland GmbH

6300 Zug

Authorization information

Swissmedic authorization number
68239
Drug name
Oxlumo, Injektionslösung
Galenic form
LSINJ
ATC Code
A16AX18
Authorization status
Z
Dispensation category
B
First authorization
01/12/2021
Authorization expiration date
31/12/9999
IT number
04.99.0.
Domain
Human medicine
Field of application
Oxlumo wird zur Behandlung der primären Hyperoxalurie Typ 1 (PH1) in allen Altersgruppen angewendet

Packaging details

Description (FR)
OXLUMO 94.5 mg / 0.5 ml sol inj 94.5 mg 1 pce
Description (DE)
OXLUMO 94.5 mg / 0.5 ml Inj Lös 94.5 mg 1 Stk
Market launch
28/03/2022
Narcotic (BTM)
No

Application methods

SUBC
Buy us a coffee Explore the data